GPR162 and neoplasm: Functional studies in murine corticotroph tumor cells demonstrated that GPR162 negatively regulates POMC mRNA expression and the GPR162 variant R218* that we had demonstrated in our index patient blunted the suppressive effect of WT GPR162.